DE934531T1 - Diagnose spongiformer encephalopathie - Google Patents
Diagnose spongiformer encephalopathieInfo
- Publication number
- DE934531T1 DE934531T1 DE0934531T DE97909428T DE934531T1 DE 934531 T1 DE934531 T1 DE 934531T1 DE 0934531 T DE0934531 T DE 0934531T DE 97909428 T DE97909428 T DE 97909428T DE 934531 T1 DE934531 T1 DE 934531T1
- Authority
- DE
- Germany
- Prior art keywords
- encephalopathy
- spongiformer
- diagnosis
- bse
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9621469.7A GB9621469D0 (en) | 1996-10-15 | 1996-10-15 | Diagnosis |
GBGB9621885.4A GB9621885D0 (en) | 1996-10-21 | 1996-10-21 | Diagnosis |
PCT/GB1997/002843 WO1998016834A1 (en) | 1996-10-15 | 1997-10-15 | Diagnosis of spongiform encephalopathy |
Publications (1)
Publication Number | Publication Date |
---|---|
DE934531T1 true DE934531T1 (de) | 2000-04-06 |
Family
ID=26310231
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69730142T Expired - Lifetime DE69730142T2 (de) | 1996-10-15 | 1997-10-15 | Diagnose spongiformer encephalopathie |
DE0934531T Pending DE934531T1 (de) | 1996-10-15 | 1997-10-15 | Diagnose spongiformer encephalopathie |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69730142T Expired - Lifetime DE69730142T2 (de) | 1996-10-15 | 1997-10-15 | Diagnose spongiformer encephalopathie |
Country Status (10)
Country | Link |
---|---|
US (1) | US6998231B2 (de) |
EP (1) | EP0934531B1 (de) |
JP (1) | JP2001503141A (de) |
AT (1) | ATE272842T1 (de) |
AU (1) | AU4711597A (de) |
CA (1) | CA2268904A1 (de) |
DE (2) | DE69730142T2 (de) |
ES (1) | ES2134749T3 (de) |
NZ (1) | NZ335290A (de) |
WO (1) | WO1998016834A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221614B1 (en) | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
US6620629B1 (en) | 1997-02-21 | 2003-09-16 | The Regents Of The University Of California | Method for detecting prions |
AT407160B (de) * | 1998-06-04 | 2001-01-25 | Immuno Ag | Verfahren zur bestimmung von antigenen |
GB2348203B (en) | 1998-11-04 | 2002-06-19 | Imp College Innovations Ltd | Solube beta-forms of prion proteins, methods of preparation and use |
GB9908059D0 (en) * | 1999-04-09 | 1999-06-02 | Imp College Innovations Ltd | Diagnosis and treatment of diseases |
EA007391B1 (ru) | 2000-07-07 | 2006-10-27 | Апплайд Резеч Системз Арс Холдинг Н.В. | Способ диагностики или выявления конформационного заболевания или его маркера и набор для использования в способе |
GB2376071A (en) * | 2001-05-31 | 2002-12-04 | Mini Agriculture & Fisheries | Method for typing a TSE strain |
GB0119339D0 (en) * | 2001-08-08 | 2001-10-03 | Medical Res Council | Method |
GB0125606D0 (en) * | 2001-10-25 | 2001-12-19 | Sec Dep For Environment Food & | Diagnostic method |
GB0227651D0 (en) * | 2002-11-27 | 2003-01-08 | Medical Res Council | Prion |
JP2008505646A (ja) * | 2004-07-09 | 2008-02-28 | クロニクス バイオメディカル | ウシ海綿状脳症に対するリスクを評価するための核酸の検出法 |
WO2007150064A2 (en) * | 2006-06-23 | 2007-12-27 | Amicus Therapeutics, Inc. | METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE |
WO2010019270A1 (en) | 2008-08-14 | 2010-02-18 | Isis Pharmaceuticals, Inc. | Modulation of prion expression |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4892814A (en) | 1987-06-22 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Method for distinguishing Creutzfeldt-Jakob disease from other dementias |
GB9117910D0 (en) * | 1991-08-20 | 1991-10-09 | Nat Res Dev | Oligonucleotides and their use in an assay |
US5789655A (en) | 1994-05-13 | 1998-08-04 | The Regents Of The University Of California | Transgenic animals expressing artificial epitope-tagged proteins |
US5908969A (en) | 1994-05-13 | 1999-06-01 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
US6008435A (en) * | 1994-05-13 | 1999-12-28 | The Regents Of The University Of California | Detecting cow, sheep and human prions in a sample and transgenic mice used for same |
US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
AU3932895A (en) | 1994-11-29 | 1996-06-19 | Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland, The | Spongiform encephalopathy detection methods |
ATE263374T1 (de) * | 1995-09-14 | 2004-04-15 | Univ California | Für natives prp-sc spezifische antikörper |
-
1997
- 1997-10-15 WO PCT/GB1997/002843 patent/WO1998016834A1/en active IP Right Grant
- 1997-10-15 DE DE69730142T patent/DE69730142T2/de not_active Expired - Lifetime
- 1997-10-15 JP JP10518114A patent/JP2001503141A/ja not_active Ceased
- 1997-10-15 EP EP97909428A patent/EP0934531B1/de not_active Expired - Lifetime
- 1997-10-15 AT AT97909428T patent/ATE272842T1/de not_active IP Right Cessation
- 1997-10-15 DE DE0934531T patent/DE934531T1/de active Pending
- 1997-10-15 NZ NZ335290A patent/NZ335290A/en unknown
- 1997-10-15 ES ES97909428T patent/ES2134749T3/es not_active Expired - Lifetime
- 1997-10-15 AU AU47115/97A patent/AU4711597A/en not_active Abandoned
- 1997-10-15 CA CA002268904A patent/CA2268904A1/en not_active Abandoned
-
2001
- 2001-02-06 US US09/778,926 patent/US6998231B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ335290A (en) | 2001-08-31 |
ES2134749T1 (es) | 1999-10-16 |
ATE272842T1 (de) | 2004-08-15 |
CA2268904A1 (en) | 1998-04-23 |
DE69730142T2 (de) | 2005-08-11 |
US20020081645A1 (en) | 2002-06-27 |
EP0934531B1 (de) | 2004-08-04 |
WO1998016834A1 (en) | 1998-04-23 |
ES2134749T3 (es) | 2005-03-16 |
JP2001503141A (ja) | 2001-03-06 |
AU4711597A (en) | 1998-05-11 |
EP0934531A1 (de) | 1999-08-11 |
US6998231B2 (en) | 2006-02-14 |
DE69730142D1 (en) | 2004-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE272842T1 (de) | Diagnose spongiformer encephalopathie | |
HUP0104890A2 (hu) | Eljárás és készlet prion protein extrahálására | |
DE69729473D1 (de) | Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems | |
BRPI0112262B8 (pt) | processo para detecção e teste para um marcador de uma doença conformacional, kit, processo para identificar um composto, processo para detectar a presença de uma forma patogênica prp sc de proteína de príon, e aparelho | |
ATE440536T1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
DE69738739D1 (de) | Verfahren für das Entwerfen von kleinen Erythropoietin Mimetika | |
ATE443147T1 (de) | Sphingosin-1-phosphat-lyase polypeptide, polynukleotide und modulierende mitteln, und verfahren zu deren verwendung | |
ES2079481T3 (es) | Un procedimiento para la determinacion de la actividad funcional de la proteina s o de la proteina c libre en una muestra de plasma. | |
PT891553E (pt) | Metodo de deteccao das encefalopatias espongiformes transmissiveis | |
CA2364686A1 (en) | Prion test | |
DE69821246D1 (de) | Testverfahren für collagenpeptid | |
ATE415632T1 (de) | Verfahren zur diagnose und behandlung von morbus crohn | |
BR0010007A (pt) | Indicadores biológicos para validação de um processo de esterilização de prìon | |
PT909388E (pt) | Ensaios imunologicos para encefalopatias espongiformes | |
ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
GB2333362A (en) | Diagnosis of spongiform encephalopathy | |
FR2849205B1 (fr) | Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification | |
DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
DE60038614D1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
DE60231106D1 (en) | Test für übertragbare spongiforme encephalopathien | |
DE69940906D1 (de) | Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln | |
ATE312914T1 (de) | Rdgb-proteine | |
BR0317224A (pt) | Processo de detecção de prp (proteìna priÈnio nativa) com uso de um antibiótico dos aminoglicosìdeos | |
ATE279143T1 (de) | Analyse zum nachweis von degenerativen hirnerkrankungen | |
FI951778A0 (fi) | Menetelmä allergian toteamiseksi |